Developing case definitions for symptom-based conditions: The problem of specificity

Epidemiologic Reviews

Volumn 20, Issue 2, 1998, Pages 148-156

  Hyams, Kenneth C ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDIASIS; CHRONIC FATIGUE SYNDROME; FIBROMYALGIA; FOOD ALLERGY; MENTAL DISEASE; MULTIPLE CHEMICAL SENSITIVITY; NEURASTHENIA; PERSIAN GULF SYNDROME; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; SICK BUILDING SYNDROME;

EID: 0032442859     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a017977     Document Type: Review

References (124)

1. Council on Scientific Affairs, American Medical Association. Council report: clinical ecology. JAMA 1992;268:3465-7.
2. Straus SE. History of chronic fatigue syndrome. Rev Infect Dis 1991;13(Suppl 1):S2-7.
3. Levine PH. Epidemic neuromyasthenia and chronic fatigue syndrome: epidemiological importance of a cluster definition. Clin Infect Dis 1994;18(Suppl 1):S16-20.
4. David AS, Wessely S, Pelosi AJ. Postviral fatigue syndrome: time for a new approach. Br Med J (Clin Res Ed) 1988;296: 696-9.
5. Beard G. Neurasthenia, or nervous exhaustion. Boston Med Surg J 1869;3:217-20.
6. Wessely S. Old wine in new bottles: neurasthenia and 'ME'. Psychol Med 1990;20:35-53.
7. Abbey SE, Garfinkel PE. Neurasthenia and chronic fatigue syndrome: the role of culture in the making of a diagnosis. Am J Psychiatry 1991;148:1638-46.
8. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108:387-9.
9. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study: International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-9.
10. Kroenke K, Spitzer RL, Williams JBW, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994;3:774-9.
11. Hickie I, Lloyd A, Hadzi-Pavlovic D, et al. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med 1995;25:925-35.
12. Komaroff AL, Fagioli LR, Geiger AM, et al. An examination of the working case definition of chronic fatigue syndrome. Am J Med 1996;100:56-64.
13. Wessely S, Chalder T, Hirsch S, et al. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatry 1996;153:1050-9.
14. Lloyd AR, Hickie I, Boughton CR, et al. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 1990;153:522-8.
15. Sharpe MC, Archard LC, Banatvala JE, et al. A report - chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84:118-21.
16. Bates DW, Buchwald D, Lee J, et al. A comparison of case definitions of chronic fatigue syndrome. Clin Infect Dis 1994;18(Suppl 1):S11-15.
17. Komaroff AL. A 56-year-old woman with chronic fatigue syndrome. JAMA 1997;278:1179-85.
18. Manu P, Lane TJ, Matthews DA. The pathophysiology of chronic fatigue syndrome: confirmations, contradictions, and conjectures. Int J Psychiatry Med 1992;22:397-408.
19. Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991;13(Suppl 1):S8-11.
20. Kruesi MJP, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry 1989;50:53-6.
21. Hickie I, Lloyd A, Wakefield D, et al. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry 1990;156:534-40.
22. Abbey SE, Garfinkel PE. Chronic fatigue syndrome and depression: cause, effect or covariate. Rev Infect Dis 1991; 13(Suppl 1):S73-83.
23. Richman JA, Flaherty JA, Rospenda KM. Chronic fatigue syndrome: have flawed assumptions been derived from treatment-based studies? Am J Public Health 1994;84: 282-4.
24. Reyes M, Gary HE Jr, Dobbins JG, et al. Surveillance for chronic fatigue syndrome - four US cities, September 1989 through August 1993. MMWR CDC Surveill Summ 1997; 46(SS-2):1-13.
25. Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. QJM 1997;90:223-33.
26. Wilson A, Hickie I, Lloyd A, et al. Longitudinal study of outcome of chronic fatigue syndrome. BMJ 1994;308:756-9.
27. Clark MR, Katon W, Russo J, et al. Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am J Med 1995;98:187-95.
28. Hadler NM. A critical reappraisal of the fibrositis concept. Am J Med 1986;81(Suppl 3A):26-30.
29. Goldenberg DL. Fibromyalgia syndrome: an emerging but controversial condition. JAMA 1987;257:2782-7.
30. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
31. Bohr T. Painful questions about fibromyalgia. JAMA 1987; 258:1476-7.
32. Sola AE, Rodenberger ML, Gettys BB. Incidence of hypersensitive areas in posterior shoulder muscles: a survey of two hundred young adults. Am J Phys Med 1955;34:585-90.
33. Hudson JI, Goldenberg DL, Pope HG Jr, et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363-7.
34. Ledingham J, Doherty S, Doherty M. Primary fibromyalgia syndrome - an outcome study. Br J Rheumatol 1993;32: 139-42.
35. Buskila D, Neumann L, Hershman E, et al. Fibromyalgia syndrome in children - an outcome study. J Rheumatol 1995; 22:525-8.
36. Russell IJ, Orr MD, Littman B, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-601.
37. Sparks PJ, Daniell W, Black DW, et al. Multiple chemical sensitivity syndrome: a clinical perspective. I. Case-definition, theories of pathogenesis, and research needs. J Occup Med 1994;36:718-30.
38. Nethercott JR, Davidoff LL, Curbow B, et al. Multiple chemical sensitivities syndrome: toward a working case definition. Arch Environ Health 1993;48:19-26.
39. Cullen MR. The worker with multiple chemical sensitivities: an overview. In: Cullen MR, ed. Occupational medicine: state of the art reviews. Philadelphia, PA: Hanley and Belfus, 1987:655-61.
40. A report on multiple chemical sensitivity (MCS): predecisional draft. The Interagency Workgroup on Multiple Chemical Sensitivity. Atlanta, GA: Agency for Toxic Substances and Disease Registry, US Department of Health and Human Services, August 1998.
41. Simon GE, Katon WJ, Sparks PJ. Allergic to life: psychological factors in environmental illness. Am J Psychiatry 1990;147:901-6.
42. Simon GE, Daniell W, Stockbridge H, et al. Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity: a controlled study. Ann Intern Med 1993;119:97-103.
43. Black DW. Environmental illness and misdiagnosis - a growing problem. Regul Toxicol Pharmacol 1993;18:23-31.
44. Ferguson A. Food sensitivity or self-deception? N Engl J Med 1990;323:476-8.
45. Pearson DJ, Rix KJB, Bentley SJ. Food allergy: how much in the mind? A clinical and psychiatric study of suspected food hypersensitivity. Lancet 1983;1:1259-61.
46. Blonz ER. Is there an epidemic of chronic candidiasis in our midst? JAMA 1986;256:3138-9.
47. Crook WG. The yeast connection handbook. Jackson, TN: Professional Books, 1996.
48. Nyren O, Yin L, Josefsson S, et al. Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden. BMJ 1998;316:417-22.
49. Solomon G, Espinoza L, Silverman S. Breast implants and connective-tissue diseases. (Letter). N Engl J Med 1994;331: 1231.
50. Bridges AJ. Rheumatic disorders in patients with silicone implants: a critical review. J Biomater Sci Polym Ed 1995; 7:147-57.
51. Silverman BG, Brown SL, Bright RA, et al. Reported complications of silicone gel breast implants: an epidemiologic review. Ann Intern Med 1996;124:744-56.
52. Scientific workshop summary: summary of the atypical rheumatic diseases and silicone breast implants workshop, April 17, 1997. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 1997.
53. Diagnostic tests for silicone breast disease. MMWR Morb Mortal Wkly Rep 1996;45:111-12.
54. Tenenbaum SA, Rice JC, Espinoza LR, et al. Use of antipolymer antibody assay in recipients of silicone breast implants. Lancet 1997;349:449-54.
55. Antipolymer antibodies, silicone breast implants, and fibromyalgia. (Letters). Lancet 1997;349:1170-3.
56. Redlich CA, Sparer J, Cullen MR. Sick-building syndrome. Lancet 1997;349:1013-16.
57. Crawford JO, Bolas SM. Sick building syndrome, work factors and occupational stress. Scand J Work Environ Health 1996;22:243-50.
58. Chester AC, Levine PH. Concurrent sick building syndrome and chronic fatigue syndrome: epidemic neuromyasthenia revisited. Clin Infect Dis 1994;18(Suppl 1):S43-8.
59. Unexplained illnesses among Desert Storm veterans: a search for causes, treatment, and cooperation: Persian Gulf Veterans Coordinating Board. Arch Intern Med 1995;155:262-8.
60. Joseph SC. A comprehensive clinical evaluation of 20,000 Persian Gulf War veterans: Comprehensive Clinical Evaluation Program Evaluation Team. Mil Med 1997;162:149-55.
61. Coker WJ. A review of Gulf war illness. J R Nav Med Serv 1996;82:141-6.
62. The Persian Gulf experience and health: NIH Technology Assessment Workshop Panel. JAMA 1994;272:391-6.
63. Murphy F, Browne D, Mather S, et al. Women in the Persian Gulf War: health care implications for active duty troops and veterans. Mil Med 1997;162:656-60.
64. Wolfe J, Proctor SP, Davis JD, et al. Health symptoms reported by Persian Gulf war veterans two years after return. Am J Ind Med 1998;33:104-13.
65. Presidential Advisory Committee on Gulf War Veterans' Illnesses: final report. Washington, DC: US GPO, 1996.
66. Haley RW, Kurt TL, Horn J. Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms. JAMA 1997;277:215-22.
67. Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychiatric Association, 1994.
68. Katon W, Kleinman A, Rosen G. Depression and somatization: a review. Part 1. Am J Med 1982;72:127-35.
69. Gerber PD, Barrett JE, Barrett JA, et al. The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 1992;7:170-3.
70. Simon GE, VonKorff M. Somatization and psychiatric disorder in the NIMH epidemiologic catchment area study. Am J Psychiatry 1991;148:1494-500.
71. Buchwald D, Goldenberg DL, Sullivan JL, et al. The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia. Arthritis Rheum 1987;30:1132-6.
72. Buchwald D, Komaroff AL. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis 1991;13(Suppl 1):S12-18.
73. Lane TJ, Matthews DA, Manu P. The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. Am J Med Sci 1990;299:313-18.
74. Mawle AC, Nisenbaum R, Dobbins JG, et al. Seroepidemiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis 1995;21:1386-9.
75. Fiedler N, Maccia C, Kipen H. Evaluation of chemically sensitive patients. J Occup Med 1992;34:529-38.
76. Wallace DJ. Fibromyalgia: unusual historical aspects and new pathogenic insights. Mt Sinai J Med 1984;51:124-31.
77. Wessely S, Chalder T, Hirsch S, et al. Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995;345: 1333-8.
78. Buchwald D, Umali J, Pearlman T, et al. Postinfectious chronic fatigue: a distinct syndrome? Clin Infect Dis 1996;23:385-7.
79. Terr AI. Environmental illness: a clinical review of 50 cases. Arch Intern Med 1986;146:145-9.
80. Sparks PJ, Daniell W, Black DW, et al. Multiple chemical sensitivity syndrome: a clinical perspective. II. Evaluation, diagnostic testing, treatment, and social considerations. J Occup Med 1994;36:731-7.
81. Straus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome: lack of efficacy in a placebo-controlled trial. N Engl J Med 1988;319:1692-8.
82. Dismukes WE, Wade JS, Lee JY, et al. A randomized, double-blind trial of nystatin therapy for the candidiasis hypersensitivity syndrome. N Engl J Med 1990;323:1717-23.
83. Jewett DL, Fein G, Greenberg MH. A double-blind study of symptom provocation to determine food sensitivity. N Engl J Med 1990;323:429-33.
84. Menzies R, Tamblyn R, Farant JP, et al. The effect of varying levels of outdoor-air supply on the symptoms of sick building syndrome. N Engl J Med 1993;328:821-7.
85. Bourbeau J, Brisson C, Allaire S. Prevalence of the sick building syndrome symptoms in office workers before and six months and three years after being exposed to a building with an improved ventilation system. Occup Environ Med 1997;54:49-53.
86. Grandjean P, Guldager B, Larsen IB, et al. Placebo response in environmental disease: chelation therapy of patients with symptoms attributed to amalgam fillings. J Occup Environ Med 1997;39:707-14.
87. Kellner R, Sheffield BF. The one-week prevalence of symptoms in neurotic patients and normals. Am J Psychiatry 1973;130:102-5.
88. Linet MS, Stewart WF, Celentano DD, et al. An epidemiologic study of headache among adolescents and young adults. JAMA 1989;261:2211-16.
89. Kroenke K, Price RK. Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993;153:2474-80.
90. Lewis G, Wessely S. The epidemiology of fatigue: more questions than answers. J Epidemiol Community Health 1992;46:92-7.
91. Stewart DE. Emotional disorders misdiagnosed as physical illness: environmental hypersensitivity, candidiasis hypersensitivity, and chronic fatigue syndrome. Int J Ment Health 1990;19:56-68.
92. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994;154:2049-53.
93. Wessely S, Powell R. Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989;52:940-8.
94. Katon WJ, Buchwald DS, Simon GE, et al. Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. J Gen Intern Med 1991;6:277-85.
95. Muscio B. Is a fatigue test possible? Br J Psychol 1921;12: 31-46.
96. May J, Kline P. Problems in using an adjective checklist to measure fatigue. Pers Individual Differences 1988;9:831-2.
97. Bennett RM. Fibromyalgia and the disability dilemma: a new era in understanding a complex, multidimensional pain syndrome. Arthritis Rheum 1996;39:1627-34.
98. Lane RS, Barsky AJ, Goodson JD. Discomfort and disability in upper respiratory tract infection. J Gen Intern Med 1988; 3:540-6.
99. Eisenberg L. What makes persons "patients" and patients "well"? Am J Med 1980;69:277-86.
100. Cope H, David A, Pelosi A, et al. Predictors of chronic "postviral" fatigue. Lancet 1994;344:864-8.
101. Macdonald LA, Sackett DL, Haynes RB, et al. Labelling in hypertension: a review of the behavioural and psychological consequences. J Chronic Dis 1984;37:933-42.
102. Anderson RC, Larson DL. Reconstruction and augmentation patients' reaction to the media coverage of silicone gel-filled implants: anxiety evaluated. Psychol Rep 1995;76:1323-30.
103. Barsky AJ III. Patients who amplify bodily sensations. Ann Intern Med 1979;91:63-70.
104. Chen MK. The epidemiology of self-perceived fatigue among adults. Prev Med 1986;15:74-81.
105. Barsky AJ, Borus JF. Somatization and medicalization in the era of managed care. JAMA 1995;274:1931-4.
106. Wheeler EO, White PD, Reed EW, et al. Neurocirculatory asthenia (anxiety neurosis, effort syndrome, neurasthenia): a twenty year follow-up study of one hundred and seventy-three patients. J Am Med Assoc 1950;142:878-89.
107. Hammond EC. Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health 1964;54:11-23.
108. Tibblin G, Bengtsson C, Furunes B, et al. Symptoms by age and sex: the population studies of men and women in Gothenburg, Sweden. Scand J Prim Health Care 1990;8:9-17.
109. Komaroff AL. 'Minor' illness symptoms: the magnitude of their burden and of our ignorance. Arch Intern Med 1990; 150:1586-7.
110. Scadding JG. Health and disease: what can medicine do for philosophy? J Med Ethics 1988;14:118-24.
111. Scadding JG. The semantic problems of psychiatry. Psychol Med 1990;20:243-8.
112. Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiol Rev 1995;17:139-51.
113. Kassirer JP. Our stubborn quest for diagnostic certainty: a cause of excessive testing. N Engl J Med 1989;320:1489-91.
114. Barrows HS, Bennett K. The diagnostic (problem solving) skill of the neurologist: experimental studies and their implications for neurological training. Arch Neurol 1972;26:273-7.
115. MacMahon B, Trichopoulos D. Epidemiology: principles and methods. 2nd ed. Boston, MA: Little, Brown, 1996.
116. Haley RW, Horn J, Roland PS, et al. Evaluation of neurologic function in Gulf War veterans: a blinded case-control study. JAMA 1997;277:223-30.
117. Loveless MO, Lloyd A, Perpich R. Summary of public policy and chronic fatigue syndrome: a perspective. Clin Infect Dis 1994;18(Suppl 1):S163-5.
118. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993;153:2759-65.
119. Goldberg D. A dimensional model for common mental disorders. Br J Psychiatry Suppl 1996;30:44-9.
120. Kendell RE. Clinical validity. Psychol Med 1989;19:45-55.
121. Ray C. Chronic fatigue syndrome and depression: conceptual and methodological ambiguities. Psychol Med 1991;21:1-9.
122. Popper KR. Conjectures and refutations: the growth of scientific knowledge. New York, NY: Routledge, 1963.
123. Straus SE, Komaroff AL, Wedner HJ. Chronic fatigue syndrome: point and counterpoint. J Infect Dis 1994;170:1-6.
124. Wessely S, Hotopf M, Sharpe M. Chronic fatigue and its syndromes. New York, NY: Oxford University Press, 1998.